- Home
- CDE vs ENOV Comparison
CDE vs ENOV Comparison
Compare CDE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDE
- ENOV
- Stock Information
- Founded
- CDE 1928
- ENOV 1995
- Country
- CDE United States
- ENOV United States
- Employees
- CDE N/A
- ENOV N/A
- Industry
- CDE Precious Metals
- ENOV Fluid Controls
- Sector
- CDE Basic Materials
- ENOV Industrials
- Exchange
- CDE Nasdaq
- ENOV Nasdaq
- Market Cap
- CDE 2.3B
- ENOV 2.4B
- IPO Year
- CDE N/A
- ENOV 2008
- Fundamental
- Price
- CDE $5.90
- ENOV $44.52
- Analyst Decision
- CDE Strong Buy
- ENOV Strong Buy
- Analyst Count
- CDE 4
- ENOV 9
- Target Price
- CDE $7.81
- ENOV $67.00
- AVG Volume (30 Days)
- CDE 9.3M
- ENOV 550.9K
- Earning Date
- CDE 02-19-2025
- ENOV 11-06-2024
- Dividend Yield
- CDE N/A
- ENOV N/A
- EPS Growth
- CDE N/A
- ENOV N/A
- EPS
- CDE N/A
- ENOV N/A
- Revenue
- CDE $1,010,652,000.00
- ENOV $2,001,668,000.00
- Revenue This Year
- CDE $32.61
- ENOV $25.59
- Revenue Next Year
- CDE $39.85
- ENOV $5.97
- P/E Ratio
- CDE N/A
- ENOV N/A
- Revenue Growth
- CDE 31.38
- ENOV 20.52
- 52 Week Low
- CDE $2.42
- ENOV $38.27
- 52 Week High
- CDE $7.72
- ENOV $65.03
- Technical
- Relative Strength Index (RSI)
- CDE 40.60
- ENOV 45.23
- Support Level
- CDE $5.68
- ENOV $41.71
- Resistance Level
- CDE $6.01
- ENOV $47.04
- Average True Range (ATR)
- CDE 0.30
- ENOV 1.37
- MACD
- CDE -0.10
- ENOV -0.44
- Stochastic Oscillator
- CDE 12.50
- ENOV 39.80
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.